Cosmos Health Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COSM research report →
Price Chart
About the company
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace.
- CEO
- Grigorios Siokas
- IPO
- 2010
- Employees
- 163
- HQ
- Thessaloniki, IL, GR
Get TickerSpark's AI analysis on COSM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $14.56M
- P/E
- -0.41
- Fwd P/E
- 3.82
- PEG
- -0.01
- P/S
- 0.20
- P/B
- 0.78
- EV/EBITDA
- -1.47
- Div Yield
- 0.00%
- Gross Margin
- 10.27%
- Op Margin
- -24.65%
- Net Margin
- -33.08%
- ROE
- -118.89%
- ROIC
- -46.45%
Latest fiscal year · YoY change
- Revenue
- $65.27M+19.9%
- Gross Profit
- $7.90M+83.1%
- Op Income
- $-16,540,819
- Net Income
- $-19,144,998-18.3%
- EPS
- $-0.63+46.2%
- OCF Growth
- -9.5%
- FCF Growth
- -4.5%
- 52W High
- $1.32
- 52W Low
- $0.16
- 50D MA
- $0.23
- 200D MA
- $0.35
- Beta
- 4.17
- RSI (14)
- 62
- Avg Volume
- 10.06M
No earnings-call transcripts are available for COSM yet.
- Free Float
- 59.7%
- Shares Outstanding
- 54.43M
- Float Shares
- 32.49M
of shares held by institutions
21 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Ubs Group AG | 594.46K | ▲ 581.73K |
| Vanguard Fiduciary Trust Co | 333.84K | ▲ 238.11K |
| Jane Street Group, LLC | 289.29K | ▲ 289.29K |
| Geode Capital Management, LLC | 282.09K | ▼ 36.02K |
| Blackrock, Inc. | 267.80K | 0 |
| Vanguard Group Inc | 235.74K | 0 |
| Vanguard Capital Management LLC | 173.97K | ▲ 33.96K |
| Northern Trust Corp | 53.89K | ▲ 33.33K |
| State Street Corp | 45.24K | 0 |
| Sassicaia Capital Advisers LLC | 36.00K | ▲ 36.00K |
| Kestra Private Wealth Services, LLC | 13.00K | ▲ 13.00K |
| Simplex Trading, LLC | 7.14K | ▲ 3.33K |
Held by 6 ETFs
Biggest fund positions in COSM by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 30, 26 | Siokas Grigorios | buy | 349,825 |
| Jul 29, 26 | Terzis Georgios | other | 328,407 |
| Jul 29, 26 | Siokas Grigorios | buy | 766,284 |
| Jun 16, 26 | Terzis Georgios | buy | 168,135 |
| Jun 11, 26 | Siokas Grigorios | buy | 218,447 |
| Jun 10, 26 | Siokas Grigorios | buy | 701,447 |
| May 19, 26 | Karkantzos Theodoros Christos | other | 20,000 |
| May 19, 26 | Karkantzos Theodoros Christos | other | 35,000 |
| May 19, 26 | Hoidas John James | other | 20,000 |
| May 19, 26 | Hoidas John James | other | 20,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our COSM coverage
Recent articles, reports, and earnings notes.
No research on COSM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate COSM report →Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market
accessnewswire.com · Sep 9
Cosmos Health: A Company Transformed — 2026 Year-to-Date
globenewswire.com · Sep 3
Cosmos Health Strengthens Balance Sheet and Streamlines Capital Structure; Retires $8M ATW Convertible Note One Year Ahead of Maturity, Eliminating Further Dilution From Conversions
globenewswire.com · Aug 28
Cosmos Health Projects Over $6M in Annual Revenue and $4.3M in Gross Profit from Oliv18™ Across the U.S. Cardiovascular Health and Antioxidant Categories
globenewswire.com · Aug 24
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term
globenewswire.com · Aug 20
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
globenewswire.com · Aug 19
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
globenewswire.com · Jul 27
Cosmos Health Advances Its Technology-Driven Transformation with an AI-Enabled Subscription Platform Across B2C and B2B Channels
globenewswire.com · Jul 27
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.